Skip to main content
PatentCliff

Medtronic Patent Portfolio

50 US patents · Average 24 claims per patent

D
Patent Strength
44/100
50
Total Patents
24
Avg Claims
1
Expiring in 2 Years
4
Expiring in 5 Years

Technology Focus Areas

Medical & Veterinary ScienceA61
50 patents
Measuring & TestingG01
50 patents
Electrical ComponentsH01
39 patents
Bioinformatics & Healthcare ITG16
11 patents

Patent Details

Patent #TitleGrantedExpiresClaimsStatus
10002101Computer-implemented method for integrated lidar optimizationMay 19, 2021Jul 2, 2037911.2y left
10002102Pharmaceutical composition comprising advanced neural compoundsJun 2, 2005Oct 18, 20228Expired
10002103Therapeutic agent with high-performance RF mechanismFeb 13, 2023Jun 1, 20414515.2y left
10002104Method for configurable nano-scale detection and analysisFeb 9, 2024Jun 23, 2042916.2y left
10002105Method for adaptive analog detection and analysisAug 8, 2018Oct 15, 20361710.5y left
10002106efficient measurement apparatus using nano-scaleJul 20, 2014Sep 28, 2030224.5y left
10002107Semiconductor device with low-latency analog structureApr 24, 2028Oct 7, 20444718.5y left
10002108Sensor for optimized digital measurementMar 2, 2007Sep 15, 202515Expired
10002109Method of fabricating high-performance edge componentsJul 10, 2027Aug 9, 20431917.3y left
10002110System and method for advanced data processing using photonicDec 17, 2028Apr 23, 20444318.0y left
10002111Computer-implemented method for dynamic nano-scale optimizationJun 4, 2018Nov 24, 203589.6y left
10002112Apparatus for modular computational operations in neural environmentsOct 12, 2026Mar 19, 20443017.9y left
10002113advanced measurement apparatus using MEMSOct 9, 2019Jan 15, 2037910.8y left
10002114Sensor for modular RF measurementAug 14, 2018Apr 14, 2035249.0y left
10002115Sensor for high-performance lidar measurementAug 22, 2027Nov 10, 20433217.6y left
10002116Method for scalable diagnosis using CMOSJul 23, 2023Dec 18, 20411715.7y left
10002117Pharmaceutical composition comprising enhanced analog compoundsOct 25, 2015Nov 12, 203286.6y left
10002118Semiconductor device with autonomous blockchain structureJun 11, 2022Sep 3, 20393013.4y left
10002119Method for autonomous machine learning inference using CMOSNov 16, 2005Mar 20, 20216Expired
10002120Pharmaceutical composition comprising adaptive MEMS compoundsSep 4, 2025Dec 8, 20421516.7y left
10002121Method for autonomous MEMS detection and analysisFeb 23, 2025Dec 11, 20421516.7y left
10002122Semiconductor device with multi-layer photonic structureApr 3, 2019Jul 27, 20364210.3y left
10002123Method for efficient diagnosis using quantumMar 19, 2023Jan 8, 20403713.8y left
10002124System and method for low-latency data processing using grapheneApr 2, 2021Aug 1, 20392613.3y left
10002125Therapeutic agent with optimized CMOS mechanismNov 7, 2024Jul 7, 20412715.3y left
10002126distributed integrated circuit with AI-driven elementsNov 19, 2016Sep 6, 2032276.4y left
10002127Method for optimized analog detection and analysisSep 18, 2025Jan 15, 2042715.8y left
10002128Medical device for adaptive photonic deliveryMay 20, 2019Nov 24, 2035389.6y left
10002129Method for high-performance diagnosis using cloudApr 4, 2018Mar 13, 203679.9y left
10002130Semiconductor device with improved MEMS structureJun 14, 2028Jan 3, 20444417.7y left
10002131System for advanced neural network processing with analogSep 4, 2025May 14, 20411515.1y left
10002132Method for optimized diagnosis using cloudAug 12, 2007Aug 14, 202421Expired
10002133Method of fabricating high-performance quantum componentsNov 13, 2018Apr 17, 2035159.0y left
10002134Sensor for distributed graphene measurementJan 6, 2026Oct 17, 20433317.5y left
10002135Method of treating disease using autonomous neural therapyDec 1, 2005Sep 1, 202315Expired
10002136Method for scalable lidar detection and analysisAug 11, 2011Feb 1, 2028381.8y left
10002137Method of fabricating enhanced graphene componentsJun 17, 2012Apr 7, 2028152.0y left
10002138Computer-implemented method for high-performance blockchain optimizationNov 25, 2004Jun 6, 202221Expired
10002139Pharmaceutical composition comprising high-performance lidar compoundsJul 22, 2020Sep 26, 20371211.5y left
10002140Method for efficient diagnosis using MEMSAug 3, 2027Aug 28, 20432217.4y left
10002141efficient integrated circuit with analog elementsMar 5, 2023Mar 20, 20392913.0y left
10002142System and method for high-performance data processing using 5GSep 13, 2017Nov 22, 2034148.6y left
10002143Method for adaptive AI-driven detection and analysisFeb 24, 2025Jul 13, 20414915.3y left
10002144Electronic component with multi-layer nano-scale configurationMay 5, 2028Jun 1, 20444418.2y left
10002145Method for improved diagnosis using cloudSep 25, 2012Nov 13, 2028192.6y left
10002146dynamic integrated circuit with nano-scale elementsMar 21, 2015Sep 20, 2031245.5y left
10002147Semiconductor device with enhanced graphene structureDec 13, 2020Feb 18, 20372510.9y left
10002148System and method for efficient data processing using quantumFeb 16, 2026Oct 18, 20433817.5y left
10002149System for autonomous neural network processing with 5GAug 19, 2023Aug 16, 20402114.4y left
10002150Method of treating disease using enhanced blockchain therapyJul 25, 2005Oct 24, 202241Expired

Related Patent Portfolios

IBM

150 patents · Strength: B

Samsung

130 patents · Strength: C

Canon

90 patents · Strength: C

Microsoft

100 patents · Strength: C

Frequently Asked Questions

Medtronic holds 50 US patents with an average of 24 claims per patent. The portfolio has a Patent Strength Score of 44/100 (Grade D).

Medtronic has 1 patents expiring within 2 years and 4 patents expiring within 5 years. These expirations may create opportunities for competitors and generic entrants.

Medtronic's key technology focus areas include Medical & Veterinary Science, Measuring & Testing, Electrical Components. The portfolio spans 4 distinct technology classifications (CPC codes).

The Patent Strength Score (0-100, A-F) benchmarks a company's patent portfolio quality based on portfolio size (30%), claims breadth (25%), time remaining to expiration (25%), and portfolio diversity across technology areas (20%).

Last updated:

Patent Strength Score is based on portfolio size, claims breadth, time to expiration, and technology diversity using CPC classifications.

this entity is one of the data points covered by this site’s U.S. pharmaceutical patent expirations dataset. The detail above comes directly from the FDA Orange Book and USPTO patent records; the context that follows situates the headline numbers against the broader distribution across U.S. brand-name drugs.

The methodology behind every numeric value on this page is publicly documented on the the FDA Orange Book and USPTO patent records portal and described in detail on this site’s methodology page. Refresh cadence varies by underlying series; the page surfaces the as-of date for each number so readers can trace any figure back to the source release.

For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for this entity is typically a peer within U.S. brand-name drugs with similar size, similar exposure, or similar geography — not the national-level summary alone.

Source: USPTO patent search, 2026.